• TRPV1 is highly expressed in triple-negative breast cancer (TNBC) and plays a role in cancer growth, metastasis, apoptosis, and pain.
• Both TRPV1 agonists and antagonists exhibit anti-cancer effects, suggesting a complex regulatory mechanism.
• TRPV1 may influence immunotherapy outcomes in TNBC, offering potential as a therapeutic target.
• This review highlights the need for further research to develop TRPV1-based treatment strategies for TNBC.
Download Full PDF: Function and mechanism of action of the TRPV1 channel in the development of triple-negative breast cancer | SinoBioData | SinoBioData